← 產業報告目錄

Cardiac Monitoring & Rhythm Management Devices Market by Type [Cardiac Monitoring (ECG, Ambulatory Monitors), Cardiac Rhythm Management [Pacemaker (Single, Leadless), Defibrillator (AED)], Application [Arrhythmia], End User [Hospital] - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2026-02-26頁數 491報告編號 MD1038

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 37.88 billion by 2031, up from USD 27.90 billion in 2026, growing at a CAGR of 6.3% over the forecast period. Market growth is driven by factors such as rising public awareness campaigns and screening programs aimed at early detection of cardiovascular diseases, which contribute to growing demand for cardiac monitoring devices, especially in high-risk populations. On the other hand, the adoption of remote monitoring and telemedicine technologies raises concerns about data security and patient privacy, which may hinder patient acceptance and adoption of these devices. “The implantable cardioverter defibrillators accounted for the largest market share in the cardiac rhythm management device market, during the forecast period.” By type, cardiac rhythm management devices in the market are classified into implantable cardioverter defibrillators and external defibrillators. In 2025, implantable cardioverter defibrillators accounted for a sizable market share because they provide continuous protection against sudden cardiac arrest by continuously monitor the heart's rhythm and deliver appropriate therapy when needed, protecting against sudden cardiac arrest. This constant monitoring and intervention offer round-the-clock protection for patients at risk of life-threatening arrhythmias, whereas external defibrillators are typically used for acute interventions in emergencies. Likewise, Implantable defibrillators are implanted surgically or via minimally invasive procedures in patients at high risk of sudden cardiac death due to underlying cardiac conditions such as ventricular arrhythmias or cardiomyopathy. They are intended for long-term use and are suitable for patients who require ongoing arrhythmia management. In contrast, external defibrillators, such as automated external defibrillators (AEDs) or manual defibrillators used in hospitals, are used mainly for emergency resuscitation in cases of cardiac arrest. The home care settings are projected to register the highest CAGR during the forecast period.” In the cardiac monitoring and rhythm management devices market, the home care segment is the fastest-growing end user due to the growing shift toward remote patient monitoring and home-based cardiac care. Advances in wearable, portable, and connected devices enable continuous monitoring and rhythm management outside traditional clinical settings, improving patient convenience and outcomes. Additionally, rising prevalence of chronic cardiac conditions, an aging population, and efforts to reduce hospitalizations and healthcare costs are further accelerating the adoption of these devices in home care environments. “The North American region accounted for the highest share.” The global cardiac monitoring and cardiac rhythm management devices market is divided into four regions: North America, Asia-Pacific, Europe, and the Rest of the World. According to the regional analysis, the North American region is likely to retain a significant market share in 2025 and beyond. The North American market is being propelled by rising cases of heart disease, increased healthcare expenditure, and greater awareness of early disease diagnosis. The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24% • By Designation: C-level - 30%, D-level - 34%, and Others - 36% • By Region: North America - 40%, Europe - 28%, Asia Pacific - 20%, and the Rest of the World – 12% The prominent players in the GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (US), Baxter (US), Medtronic (Ireland), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (US), Stryker (US), NIHON KOHDEN CORPORATION (Japan), MicroPort Scientific Corporation (China), FUKUDA DENSHI (Japan), OSI Systems, Inc. (US), iRhythm Inc. (US), Lepu Medical Technology (Beijing) Co., Ltd. (China), and AliveCor, Inc. (US) among others. Research Coverage This report studies the Cardiac monitoring and cardiac rhythm management devices market based on type, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets by their individual growth trends and forecasts market segment revenue for five central regions (and the respective countries in these regions). Reasons to Buy the Report The report will enable established firms as well as entrants/smaller firms to gauge the market pulse, which, in turn, will help them garner a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence. This report provides insights into the following pointers: • Analysis of key drivers (rapidly expanding global geriatric population and subsequent surge in cardiac diseases, increasing incidence of lifestyle and cardiovascular diseases), restraints (rapidly expanding global geriatric population and subsequent surge in cardiac diseases • Increasing incidence of lifestyle and cardiovascular diseases), opportunities (untapped growth potential in emerging markets), and challenges (frequent product recalls) influencing the growth of the cardiac monitoring and cardiac rhythm management devices market  Market Penetration: Comprehensive information on the product portfolios offered by the top players in the Cardiac monitoring and cardiac rhythm management devices market  Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product developments in the Cardiac monitoring and cardiac rhythm management devices market  Market Development: Comprehensive information on lucrative emerging regions  Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the Cardiac monitoring and cardiac rhythm management devices market  Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
目錄 Table of Contents
1 INTRODUCTION 43 1.1 STUDY OBJECTIVES 43 1.2 MARKET DEFINITION 43 1.3 TUDY SCOPE 44 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 44 1.3.2 INCLUSIONS & EXCLUSIONS 45 1.3.3 YEARS CONSIDERED 45 1.3.4 CURRENCY CONSIDERED 46 1.4 STAKEHOLDERS 46 1.5 SUMMARY OF CHANGES 47 2 EXECUTIVE SUMMARY 48 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 48 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 50 2.3 DISRUPTIVE TRENDS IN MARKET 51 2.4 HIGH-GROWTH SEGMENTS 52 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 53 3 PREMIUM INSIGHTS 54 3.1 CARDIAC MONITORING AND RHYTHM MANAGEMENT MARKET DEVICES MARKET OVERVIEW 54 3.2 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION AND COUNTRY 55 3.3 GEOGRAPHIC SNAPSHOT OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 56 4 MARKET OVERVIEW 57 4.1 INTRODUCTION 57 4.2 MARKET DYNAMICS 57 4.2.1 DRIVERS 58 4.2.1.1 Rising geriatric population with chronic cardiovascular diseases 58 4.2.1.2 Increasing incidence of lifestyle and cardiovascular diseases 58 4.2.1.3 Development of wireless monitoring and wearable cardiac devices 59 4.2.1.4 Rapid adoption of leadless pacemakers 59 4.2.1.5 Increasing focus on providing public-access defibrillators 60 4.2.2 RESTRAINTS 61 4.2.2.1 Increasing regulatory scrutiny extending time-to-market for cardiac devices 61 4.2.2.2 High device costs and reimbursement gaps 61   4.2.3 OPPORTUNITIES 61 4.2.3.1 Untapped growth potential in emerging markets 61 4.2.3.2 Emergence of leadless CRT platforms 62 4.2.4 CHALLENGES 62 4.2.4.1 Frequent product recalls 62 4.3 UNMET NEEDS & WHITE SPACES 63 4.3.1 UNMET NEEDS 63 4.3.2 WHITE SPACE OPPORTUNITIES 64 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 64 4.4.1 INTERCONNECTED MARKETS 64 4.4.2 CROSS-SECTOR OPPORTUNITIES 65 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 66 4.5.1 KEY STRATEGIC MOVES BY TIER-1/2/3 PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 66 5 INDUSTRY TRENDS 67 5.1 PORTER’S FIVE FORCES ANALYSIS 67 5.1.1 THREAT OF NEW ENTRANTS 68 5.1.2 THREAT OF SUBSTITUTES 68 5.1.3 BARGAINING POWER OF BUYERS 69 5.1.4 BARGAINING POWER OF SUPPLIERS 69 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 69 5.2 MACROECONOMICS OUTLOOK 69 5.2.1 GDP TRENDS AND FORECAST 69 5.2.2 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 70 5.2.3 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 71 5.3 SUPPLY CHAIN ANALYSIS 71 5.4 VALUE CHAIN ANALYSIS 72 5.5 ECOSYSTEM ANALYSIS 73 5.5.1 ROLE IN ECOSYSTEM 74 5.6 PRICING ANALYSIS 74 5.6.1 AVERAGE SELLING PRICE TREND OF CARDIAC MONITORING DEVICES, BY KEY PLAYER, 2024 AND 2025 (USD) 75 5.6.1.1 Average selling price of Holter monitors, by key player, 2025 75 5.6.1.2 Average selling price of external defibrillators, by key player, 2024 76 5.6.2 AVERAGE SELLING PRICE TREND OF CARDIAC RHYTHM MANAGEMENT DEVICES, BY REGION, 2023–2025 76 5.7 TRADE ANALYSIS 77 5.7.1 IMPORT DATA FOR HS CODE 901811, 2021–2024 78 5.7.2 EXPORT DATA FOR HS CODE 901811, 2021–2024 78 5.8 KEY CONFERENCES & EVENTS, 2025–2026 79 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 79 5.10 INVESTMENT & FUNDING SCENARIO 80 5.11 CASE STUDY ANALYSIS 81 5.11.1 DUAL-CHAMBER LEADLESS PACEMAKER BY ABBOTT 81 5.11.2 CARDIOSOFT ECG-BICESTER HEALTH CENTRE IN NUMED HEALTHCARE 81 5.11.3 POST-STROKE ATRIAL FIBRILLATION DETECTION WITH PHILIPS BIOTEL HEART MCOT 82 5.12 IMPACT OF 2025 US TARIFF ON CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 83 5.12.1 KEY TARIFF RATES 84 5.12.2 PRICE IMPACT ANALYSIS 84 5.12.3 IMPACT ON COUNTRY/REGION 85 5.12.4 IMPACT ON END-USE INDUSTRIES 87 6 DSTRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS 89 6.1 TECHNOLOGY ANALYSIS 89 6.1.1 KEY EMERGING TECHNOLOGIES 89 6.1.1.1 Artificial intelligence (AI) and predictive analytics 89 6.1.1.2 Miniaturization of cardiac devices 89 6.1.2 COMPLEMENTARY TECHNOLOGIES 90 6.1.2.1 Wearable biosensors 90 6.1.3 ADJACENT TECHNOLOGIES 90 6.1.3.1 Vital sign monitors 90 6.2 TECHNOLOGY/PRODUCT ROADMAP 91 6.2.1 NEAR TERM (2025–2027) 91 6.2.2 MID TERM (2028–2030) 91 6.2.3 LONG TERM (2030+) 92 6.3 PATENT ANALYSIS 92 6.3.1 JURISDICTION AND TOP APPLICANT ANALYSIS 92 6.4 FUTURE APPLICATIONS 95 6.4.1 FULLY AUTONOMOUS CARDIAC DIAGNOSTICS & DECISION-SUPPORT ECOSYSTEMS 95 6.4.2 PRECISION RHYTHM MANAGEMENT THROUGH PREDICTIVE & PRE-EMPTIVE THERAPY DELIVERY 95 6.4.3 FULLY LEADLESS, MODULAR, AND WIRELESSLY NETWORKED CARDIAC SYSTEMS 95 6.4.4 REGENERATIVE-INTEGRATED RHYTHM MANAGEMENT SYSTEMS 95 6.5 IMPACT OF AI/GEN AI ON CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 96 6.5.1 MARKET POTENTIAL OF AI 96 6.5.2 AI USE CASES 96 6.5.3 KEY COMPANIES IMPLEMENTING AI 98 6.5.4 BEST PRACTICES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES 99 6.5.5 CASE STUDIES OF AI IMPLEMENTATION 100 6.5.6 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 101 6.5.7 CLIENTS’ READINESS TO ADOPT GENERATIVE AI 102 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 103 7.1 REGULATORY LANDSCAPE 103 7.1.1 REGULATORY FRAMEWORK 103 7.1.1.1 North America 103 7.1.1.2 Europe 103 7.1.1.3 Asia Pacific 103 7.1.1.4 Latin America 103 7.1.1.5 Middle East & Africa 103 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104 7.1.3 INDUSTRY STANDARDS 107 7.2 SUSTAINABILITY INITIATIVES 107 7.2.1 RECYCLABLE BIOMATERIALS FOR ECG PATCHES 107 7.2.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 108 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 108 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 110 8.1 KEY STAKEHOLDERS & BUYING CRITERIA 110 8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 110 8.1.2 BUYING CRITERIA 111 8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 111 8.2.1 DECISION-MAKING PROCESS 111 8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES 112 8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 113 8.2.4 MARKET PROFITABILITY 113 9 RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE 115 9.1 INTRODUCTION 116 9.2 PACEMAKERS 116 9.2.1 SINGLE-CHAMBER PACEMAKERS 118 9.2.1.1 Increasing use of single-chamber pacemakers for managing bradyarrhythmias and conduction disorders to aid market growth 118 9.2.2 DUAL-CHAMBER PACEMAKERS 120 9.2.2.1 Dual-chamber pacemakers to witness high demand with widespread usage 120 9.2.3 LEADLESS CHAMBER PACEMAKERS 122 9.2.3.1 Focus on minimally invasive implantation and reduced complication rates to propel market growth 122   9.3 DEFIBRILLATORS 124 9.3.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS) 126 9.3.1.1 Single-chamber implantable cardioverter-defibrillators (ICDs) 129 9.3.1.1.1 Utilization in arterial monitoring to support market growth 129 9.3.1.2 Dual-chamber implantable cardioverter-defibrillators (ICDs) 131 9.3.1.2.1 Ability to reduce incidence of inappropriate shocks to drive market 131 9.3.1.3 Subcutaneous implantable cardioverter-defibrillators (ICDs) 133 9.3.1.3.1 Benefits of eliminating cardiac leads to drive market 133 9.3.2 EXTERNAL DEFIBRILLATORS 135 9.3.2.1 Automated external defibrillators (AEDs) 137 9.3.2.1.1 Smart automated external defibrillators advancing public cardiac emergency response to aid market growth 137 9.3.2.2 Manual external defibrillators 139 9.3.2.2.1 Innovation in manual external defibrillators to enhance emergency cardiac care 139 9.3.2.3 Wearable cardioverter defibrillators (WCDs) 141 9.3.2.3.1 Operational difficulties and false alarms to restrain market adoption 141 9.4 CARDIAC RESYNCHRONIZATION THERAPY (CRT) 143 9.4.1 CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS (CRT-P) 143 9.4.2 CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATORS (CRT-D) 145 10 CARDIAC MONITORING DEVICES MARKET, BY TYPE 147 10.1 INTRODUCTION 148 10.2 NON-INVASIVE CARDIAC MONITORING DEVICES 148 10.2.1 ELECTROCARDIOGRAM (ECG/EKG) MONITORS 148 10.2.1.1 Standard 12-lead ECG machines (resting ECG monitors) 151 10.2.1.1.1 Wide availability of resting ECG devices to support market growth 151 10.2.1.2 Stress ECG systems 153 10.2.1.2.1 High cost of stress ECG devices to limit adoption 153 10.2.1.3 Handheld/Smart ECG monitors 155 10.2.1.3.1 Rising adoption of AI technology and growing need to minimize treatment costs to support market growth 155 10.2.2 AMBULATORY CARDIAC MONITORS 157 10.2.2.1 Holter monitors 159 10.2.2.1.1 Growing demand for continuous monitoring to fuel segment growth 159 10.2.2.2 Event monitors 161 10.2.2.2.1 Increasing outsourcing of monitoring devices to propel market growth 161 10.2.2.3 Mobile cardiac telemetry (MCT) devices 163 10.2.2.3.1 Increasing demand for cardiac monitoring solutions in home care settings to aid segment growth 163 10.2.2.4 Long-term continuous ECG monitors 165 10.2.2.4.1 Increasing adoption of patch-based ECG monitors for extended ambulatory cardiac monitoring to aid market growth 165 10.3 INVASIVE CARDIAC MONITORING DEVICES 167 10.3.1 INTRODUCTION OF TECHNOLOGICALLY ADVANCED IMPLANTABLE LOOP RECORDERS TO SUPPORT MARKET GROWTH 167 11 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION 169 11.1 INTRODUCTION 170 11.2 ARRHYTHMIAS 170 11.2.1 GROWING NUMBER OF ATRIAL FIBRILLATION CASES TO DRIVE MARKET 170 11.3 HEART FAILURE 172 11.3.1 GROWING PREVALENCE OF CHRONIC LIFESTYLE DISEASES TO DRIVE PREVALENCE OF HEART FAILURE 172 11.4 MYOCARDIAL INFARCTION (MI) 173 11.4.1 RISING GERIATRIC POPULATION TO SPUR MARKET GROWTH 173 11.5 OTHER APPLICATIONS 175 12 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER 177 12.1 INTRODUCTION 178 12.2 HOSPITALS 178 12.2.1 INCREASING UTILIZATION OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES IN HOSPITALS TO AID MARKET GROWTH 178 12.3 PRIMARY CARE CENTERS 180 12.3.1 WIDENING ACCESS TO ECG MONITORING IN PRIMARY CARE CENTERS TO BOOST MARKET PENETRATION 180 12.4 CARDIAC CENTERS 182 12.4.1 INCREASED INCIDENCE OF CARDIOVASCULAR DISEASE AND HIGH DEMAND FOR SPECIALIZED CARE TO BOOST MARKET GROWTH 182 12.5 AMBULATORY SURGICAL CENTERS 184 12.5.1 GROWING NEED FOR PRE-OPERATIVE CARDIAC SCREENING IN AMBULATORY SURGICAL CENTERS TO INFLUENCE MARKET DEMAND 184 12.6 HOME CARE SETTINGS 186 12.6.1 RISING PREFERENCE FOR REMOTE CARDIAC MONITORING TO FUEL MARKET GROWTH 186 12.7 OTHER END USERS 187   13 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY REGION 189 13.1 INTRODUCTION 190 13.2 NORTH AMERICA 191 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 191 13.2.2 US 198 13.2.2.1 US to dominate North American cardiac monitoring and rhythm management devices market during forecast period 198 13.2.3 CANADA 204 13.2.3.1 High burden of cardiovascular diseases to support market growth 204 13.3 EUROPE 209 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 209 13.3.2 GERMANY 215 13.3.2.1 High healthcare spending to propel market growth 215 13.3.3 FRANCE 220 13.3.3.1 Favorable government initiatives to support market growth 220 13.3.4 UK 225 13.3.4.1 Rising demand for home-based smart ECG devices to support market growth 225 13.3.5 ITALY 230 13.3.5.1 Growing focus on improvements in patient care to drive market 230 13.3.6 SPAIN 235 13.3.6.1 Rising geriatric population to support market growth in Spain 235 13.3.7 AUSTRIA 241 13.3.7.1 Favourable insurance coverage for cardiac diagnostic procedures to support market growth 241 13.3.8 NETHERLANDS 246 13.3.8.1 Strong primary care referral pathway to aid adoption of cardiac monitoring and rhythm devices 246 13.3.9 SWEDEN 251 13.3.9.1 Expansion of long-term ambulatory ECG monitoring to augment market growth 251 13.3.10 REST OF EUROPE 256 13.4 ASIA PACIFIC 261 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 262 13.4.2 JAPAN 268 13.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth 268 13.4.3 CHINA 274 13.4.3.1 Government support for infrastructural improvement to drive market 274 13.4.4 INDIA 279 13.4.4.1 Increasing cardiac disease burden intensifies demand for cardiac monitoring and rhythm management devices 279 13.4.5 AUSTRALIA 285 13.4.5.1 Australia to strengthen community access to rhythm management devices through policy and targeted funding 285 13.4.6 SOUTH KOREA 290 13.4.6.1 Rising geriatric population to propel market growth 290 13.4.7 REST OF ASIA PACIFIC 296 13.5 LATIN AMERICA 301 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 302 13.5.2 BRAZIL 307 13.5.2.1 Improving access to diagnostic services to drive market growth 307 13.5.3 MEXICO 312 13.5.3.1 Rising incidences of heart disease to propel market growth 312 13.5.4 COLOMBIA 317 13.5.4.1 High arrhythmia burden to drive demand for cardiac rhythm monitoring in Colombia 317 13.5.5 REST OF LATIN AMERICA 322 13.6 MIDDLE EAST & AFRICA 327 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 332 13.6.2 GCC COUNTRIES 332 13.6.2.1 Kingdom of Saudi Arabia 338 13.6.2.1.1 High prevalence of cardiovascular diseases and increased demand for cardiac diagnostic solutions to drive market 338 13.6.2.2 UAE 343 13.6.2.2.1 Focus on national CVD screening programs and digital health strategies to augment market growth 343 13.6.2.3 Rest of GCC Countries 348 13.6.3 REST OF MIDDLE EAST & AFRICA 354 14 COMPETITIVE LANDSCAPE 360 14.1 INTRODUCTION 360 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 360 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 360 14.3 REVENUE ANALYSIS, 2022–2024 362 14.4 MARKET SHARE ANALYSIS, 2025 362 14.5 BRAND COMPARISON 366 14.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 367 14.6.1 STARS 367 14.6.2 EMERGING LEADERS 367 14.6.3 PERVASIVE PLAYERS 367 14.6.4 PARTICIPANTS 367 14.6.5 COMPANY PRODUCT FOOTPRINT: KEY PLAYERS, 2024 369 14.6.5.1 Company footprint 369 14.6.5.2 Region footprint 370 14.6.5.3 Type footprint 371 14.6.5.4 Type footprint 372 14.6.5.5 Application footprint 373 14.7 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2024 374 14.7.1 PROGRESSIVE COMPANIES 374 14.7.2 RESPONSIVE COMPANIES 374 14.7.3 DYNAMIC COMPANIES 374 14.7.4 STARTING BLOCKS 374 14.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 376 14.7.5.1 Detailed list of key startups/SMEs 376 14.7.5.2 Competitive benchmarking of key startups/SMEs 376 14.8 COMPANY VALUATION & FINANCIAL METRICS 377 14.8.1 FINANCIAL METRICS 377 14.8.2 COMPANY VALUATION 377 14.9 COMPETITIVE SCENARIO 378 14.9.1 PRODUCT LAUNCHES & APPROVALS 378 14.9.2 DEALS 380 14.9.3 EXPANSIONS 382 14.9.4 OTHER DEVELOPMENTS 383 15 COMPANY PROFILES 385 15.1 KEY PLAYERS 385 15.1.1 GE HEALTHCARE 385 15.1.1.1 Business overview 385 15.1.1.2 Products offered 387 15.1.1.3 Recent developments 388 15.1.1.3.1 Deals 388 15.1.1.3.2 Other developments 389 15.1.1.4 MnM view 389 15.1.1.4.1 Right to win 389 15.1.1.4.2 Strategic choices 389 15.1.1.4.3 Weaknesses & competitive threats 390 15.1.2 KONINKLIJKE PHILIPS N.V. 391 15.1.2.1 Business overview 391 15.1.2.2 Products offered 392 15.1.2.3 Recent developments 395 15.1.2.3.1 Product launches 395 15.1.2.3.2 Deals 396 15.1.2.3.3 Expansions 397 15.1.2.3.4 Other developments 397   15.1.2.4 MnM view 397 15.1.2.4.1 Right to win 397 15.1.2.4.2 Strategic choices 398 15.1.2.4.3 Weaknesses & competitive threats 398 15.1.3 BOSTON SCIENTIFIC CORPORATION 399 15.1.3.1 Business overview 399 15.1.3.2 Products offered 400 15.1.3.3 Recent developments 402 15.1.3.3.1 Product approvals 402 15.1.3.3.2 Deals 403 15.1.3.4 MnM view 403 15.1.3.4.1 Right to win 403 15.1.3.4.2 Strategic choices 403 15.1.3.4.3 Weaknesses & competitive threats 403 15.1.4 BAXTER (HILL-ROM HOLDINGS, INC.) 404 15.1.4.1 Business overview 404 15.1.4.2 Products offered 405 15.1.5 MEDTRONIC 408 15.1.5.1 Business overview 408 15.1.5.2 Products offered 410 15.1.5.3 Recent developments 414 15.1.5.3.1 Product approvals 414 15.1.5.4 MnM view 415 15.1.5.4.1 Right to win 415 15.1.5.4.2 Strategic choices 415 15.1.5.4.3 Weaknesses & competitive threats 415 15.1.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 416 15.1.6.1 Business overview 416 15.1.6.2 Products offered 417 15.1.6.3 Recent developments 419 15.1.6.3.1 Product launches & approvals 419 15.1.6.3.2 Other developments 419 15.1.7 ABBOTT 420 15.1.7.1 Business overview 420 15.1.7.2 Products offered 421 15.1.7.3 Recent developments 423 15.1.7.3.1 Product launches & approvals 423   15.1.8 STRYKER 424 15.1.8.1 Business overview 424 15.1.8.2 Products offered 426 15.1.8.3 Recent developments 426 15.1.8.3.1 Product launches 426 15.1.8.3.2 Deals 427 15.1.8.3.3 Other developments 427 15.1.9 NIHON KOHDEN CORPORATION 428 15.1.9.1 Business overview 428 15.1.9.2 Products offered 429 15.1.10 MICROPORT SCIENTIFIC CORPORATION 432 15.1.10.1 Business overview 432 15.1.10.2 Products offered 433 15.1.10.3 Recent developments 435 15.1.10.3.1 Product launches and approvals 435 15.1.11 FUKUDA DENSHI 437 15.1.11.1 Business overview 437 15.1.11.2 Products offered 438 15.1.12 OSI SYSTEMS, INC. 441 15.1.12.1 Business overview 441 15.1.12.2 Products offered 442 15.1.12.3 Recent developments 444 15.1.12.3.1 Expansions 444 15.1.13 IRHYTHM INC. 445 15.1.13.1 Business overview 445 15.1.13.2 Products offered 446 15.1.13.3 Recent developments 446 15.1.13.3.1 Product launches and approvals 446 15.1.13.3.2 Deals 447 15.1.14 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 448 15.1.14.1 Business overview 448 15.1.14.2 Products offered 449 15.1.14.3 Recent developments 452 15.1.14.3.1 Product launches 452 15.1.15 ALIVECOR, INC. 453 15.1.15.1 Business overview 453 15.1.15.2 Products offered 453 15.1.15.3 Recent developments 454 15.1.15.3.1 Product launches and approvals 454 15.1.15.3.2 Deals 454   15.2 OTHER PLAYERS 456 15.2.1 SCHILLER 456 15.2.2 CARDIAC INSIGHT, INC. 457 15.2.3 BIOTRONIK 458 15.2.4 BITTIUM 459 15.2.5 BPL MEDICAL TECHNOLOGIES 460 15.2.6 LIFESIGNALS 461 15.2.7 CUMEDICAL 462 15.2.8 BIOTRICITY 463 15.2.9 EDAN INSTRUMENTS, INC. 464 15.2.10 VITALCONNECT 465 16 RESEARCH METHODOLOGY 466 16.1 RESEARCH DATA 466 16.1.1 SECONDARY DATA 467 16.1.1.1 Key secondary sources 467 16.1.1.2 Key data from secondary sources 468 16.1.2 PRIMARY DATA 468 16.1.2.1 Primary sources 469 16.1.2.2 Key objectives of primary research 469 16.1.2.3 Key industry insights 470 16.1.2.4 Breakdown of primaries 471 16.2 MARKET SIZE ESTIMATION OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES 472 16.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) 472 16.2.2 MNM REPOSITORY ANALYSIS 473 16.2.3 COMPANY INVESTORS PRESENTATIONS AND PRIMARY INTERVIEWS 473 16.2.4 TOP-DOWN APPROACH 473 16.2.5 BOTTOM-UP APPROACH 474 16.2.6 PRIMARY INTERVIEWS 474 16.2.7 DEMAND-SIDE APPROACH 475 16.3 MARKET GROWTH RATE PROJECTION 475 16.4 DATA TRIANGULATION 476 16.4.1 STUDY ASSUMPTIONS 478 16.4.2 RESEARCH LIMITATIONS 478 16.5 RISK ANALYSIS 479   17 APPENDIX 480 17.1 DISCUSSION GUIDE 480 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 486 17.3 CUSTOMIZATION OPTIONS 488 17.3.1 COMPANY INFORMATION 488 17.3.2 GEOGRAPHIC ANALYSIS 488 17.3.3 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 488 17.3.4 COUNTRY-LEVEL VOLUME ANALYSIS 488 17.3.5 ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUEST 488 17.4 RELATED REPORTS 489 17.5 AUTHOR DETAILS 490
圖表清單 List of Tables & Figures
TABLE 1 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: INCLUSIONS & EXCLUSIONS 45 TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 46 TABLE 3 PRODUCT RECALLS BY US FDA, 2022–2025 63 TABLE 4 IMPACT OF PORTER’S FIVE FORCES ON CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 67 TABLE 5 GDP CHANGE, BY COUNTRY, 2021–2030 (USD BILLION) 69 TABLE 6 ROLE OF KEY COMPANIES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET ECOSYSTEM 74 TABLE 7 AVERAGE SELLING PRICE TREND OF HOLTER MONITORS, BY REGION, 2023–2025 (USD) 76 TABLE 8 AVERAGE SELLING PRICE TREND 0F EXTERNAL DEFIBRILLATORS, BY REGION, 2023–2025 ((USD) 77 TABLE 9 IMPORT DATA FOR HS CODE 901811, BY COUNTRY, 2021–2024 (USD THOUSAND) 78 TABLE 10 EXPORT DATA FOR HS CODE 901811, BY COUNTRY, 2021–2024 (USD THOUSAND) 78 TABLE 11 MAJOR CONFERENCES & EVENTS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, JANUARY 2025–DECEMBER 2026 79 TABLE 12 CASE STUDY 1: DUAL-CHAMBER LEADLESS PACEMAKER BY ABBOTT 81 TABLE 13 CASE STUDY 2: CARDIOSOFT ECG-BICESTER HEALTH CENTRE IN NUMED HEALTHCARE 81 TABLE 14 CASE STUDY 3: POST-STROKE ATRIAL FIBRILLATION DETECTION WITH PHILIPS BIOTEL HEART MCOT 82 TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES, 2024 84 TABLE 16 KEY PRODUCT-RELATED TARIFF EFFECTIVE 84 TABLE 17 IMPACT OF US TARIFF ON CANADA 85 TABLE 18 IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA 85 TABLE 19 IMPACT OF US TARIFF ON GERMANY AND UK 86 TABLE 20 IMPACT OF US TARIFF ON MEXICO 87 TABLE 21 KEY PATENTS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2023–2025 94 TABLE 22 BEST PRACTICES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 99 TABLE 23 CASE STUDIES RELATED TO AI IMPLEMENTATION IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 100 TABLE 24 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 101 TABLE 25 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104 TABLE 26 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104 TABLE 27 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 105 TABLE 28 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106 TABLE 29 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106 TABLE 30 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES 110 TABLE 31 KEY BUYING CRITERIA FOR CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES 111 TABLE 32 RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 116 TABLE 33 RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 116 TABLE 34 RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY COUNTRY, 2024–2031 (USD MILLION) 117 TABLE 35 SINGLE-CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119 TABLE 36 DUAL-CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 37 LEADLESS CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 38 RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 124 TABLE 39 RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY COUNTRY, 2024–2031(USD MILLION) 125 TABLE 40 KEY COMMERCIAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 126 TABLE 41 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 127 TABLE 42 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 43 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 44 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 45 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 46 KEY COMMERCIAL EXTERNAL DEFIBRILLATORS 135 TABLE 47 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE , 2024–2031 (USD MILLION) 135 TABLE 48 EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 49 AUTOMATED EXTERNAL DEFIBRILLATORS (AEDS) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 50 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 51 WEARABLE CARDIOVERTER DEFIBRILLATORS (WCDS) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 52 CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS (CRT-P) MARKET, BY TYPE, 2024–2031 (USD MILLION) 143 TABLE 53 CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS (CRT-P) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 54 CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATORS (CRT-D) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 55 RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 148 TABLE 56 ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 149 TABLE 57 ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 58 ELECTROCARDIOGRAM (ECG/EKG) MONITORS VOLUME, BY COUNTRY, 2024–2031 (THOUSAND UNITS) 151 TABLE 59 STANDARD 12-LEAD ECG MACHINES (RESTING ECG MONITORS) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 60 STRESS ECG SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 61 STRESS ECG SYSTEMS VOLUME, BY COUNTRY, 2024–2031 (THOUSAND UNITS) 155 TABLE 62 HANDHELD/SMART ECG MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 63 AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 157 TABLE 64 AMBULATORY CARDIAC MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 65 HOLTER MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 66 EVENT MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 67 MOBILE CARDIAC TELEMETRY (MCT) DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 68 LONG-TERM CONTINUOUS ECG MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 69 INVASIVE CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 70 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 170 TABLE 71 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR ARRHYTHMIAS, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 72 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR HEART FAILURE, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 73 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR MYOCARDIAL INFARCTION (MI), 2024–2031 (USD MILLION) 174 TABLE 74 CARDIAC MONITORING AND RHYTHM MANAGEMENT MARKET DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 176 TABLE 75 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 178 TABLE 76 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 77 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR PRIMARY CARE CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 78 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC CENTERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 183 TABLE 79 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 185 TABLE 80 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 81 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 82 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 190 TABLE 83 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 84 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 193 TABLE 85 NORTH AMERICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 193 TABLE 86 NORTH AMERICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 194 TABLE 87 NORTH AMERICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 194 TABLE 88 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 89 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 90 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 91 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 196 TABLE 92 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR EXTERNAL DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 196 TABLE 93 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 197 TABLE 94 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 197 TABLE 95 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 198 TABLE 96 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 97 US: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 98 US: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 99 US: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 200 TABLE 100 US: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 101 US: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 102 US: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 103 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 104 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 105 US: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 106 US: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 203 TABLE 107 US: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 203 TABLE 108 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 109 CANADA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 110 CANADA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 205 TABLE 111 CANADA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 205 TABLE 112 CANADA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 206 TABLE 113 CANADA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 206 TABLE 114 CANADA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 206 TABLE 115 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 207 TABLE 116 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 207 TABLE 117 CANADA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 118 CANADA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 208 TABLE 119 CANADA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 209 TABLE 120 EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 210 TABLE 121 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 210 TABLE 122 EUROPE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 211 TABLE 123 EUROPE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 211 TABLE 124 EUROPE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 211 TABLE 125 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 126 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 127 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 128 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 129 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 130 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 131 EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 214 TABLE 132 EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 215 TABLE 133 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 216 TABLE 134 GERMANY: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 216 TABLE 135 GERMANY: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 216 TABLE 136 GERMANY: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 137 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 138 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 139 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 140 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 141 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 142 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 143 GERMANY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 219 TABLE 144 GERMANY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 220 TABLE 145 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 146 FRANCE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 147 FRANCE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 148 FRANCE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 149 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 150 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 151 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 152 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 153 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 154 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 155 FRANCE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 224 TABLE 156 FRANCE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 225 TABLE 157 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 225 TABLE 158 UK: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 159 UK: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 160 UK: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 226 TABLE 161 UK: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 162 UK: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 163 UK: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 164 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 165 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 166 UK: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 229 TABLE 167 UK: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 229 TABLE 168 UK: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 230 TABLE 169 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 170 ITALY: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 171 ITALY: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 172 ITALY: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 232 TABLE 173 ITALY: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 174 ITALY: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 175 ITALY: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 233 TABLE 176 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 233 TABLE 177 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 178 ITALY: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 179 ITALY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 235 TABLE 180 ITALY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 235 TABLE 181 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 182 SPAIN: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 183 SPAIN: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 237 TABLE 184 SPAIN: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 237 TABLE 185 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 237 TABLE 186 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 187 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 188 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 189 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 190 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 191 SPAIN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 240 TABLE 192 SPAIN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 241 TABLE 193 AUSTRIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 194 AUSTRIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 195 AUSTRIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 196 AUSTRIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 243 TABLE 197 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 198 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 199 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 200 AUSTRIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 201 AUSTRIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 202 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 203 AUSTRIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 245 TABLE 204 AUSTRIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 246 TABLE 205 NETHERLANDS: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 247 TABLE 206 NETHERLANDS: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 247 TABLE 207 NETHERLANDS: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 247 TABLE 208 NETHERLANDS: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 248 TABLE 209 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 210 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 211 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 212 NETHERLANDS: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 213 NETHERLANDS: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 214 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 215 NETHERLANDS: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 251 TABLE 216 NETHERLANDS: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 251 TABLE 217 SWEDEN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 218 SWEDEN: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 219 SWEDEN: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 220 SWEDEN: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 221 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 222 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 223 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 224 SWEDEN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 225 SWEDEN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 226 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 227 SWEDEN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 255 TABLE 228 SWEDEN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 256 TABLE 229 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 230 REST OF EUROPE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 231 REST OF EUROPE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 232 REST OF EUROPE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 258 TABLE 233 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 234 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 235 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 236 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 237 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 238 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 239 REST OF EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 261 TABLE 240 REST OF EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 261 TABLE 241 ASIA PACIFIC: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 263 TABLE 242 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 243 ASIA PACIFIC: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 244 ASIA PACIFIC: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION 264 TABLE 245 ASIA PACIFIC: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 265 TABLE 246 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 247 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 248 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 249 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 250 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 251 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 252 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 268 TABLE 253 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 268 TABLE 254 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 255 JAPAN: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 256 JAPAN: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 257 JAPAN: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 270 TABLE 258 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 259 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 260 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 261 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 262 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 263 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 264 JAPAN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 273 TABLE 265 JAPAN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 274 TABLE 266 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 267 CHINA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 268 CHINA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 269 CHINA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 276 TABLE 270 CHINA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 271 CHINA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 272 CHINA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 273 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 274 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 275 CHINA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 276 CHINA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 279 TABLE 277 CHINA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 279 TABLE 278 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 279 INDIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 280 INDIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 281 INDIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 281 TABLE 282 INDIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 283 INDIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 284 INDIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 285 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 283 TABLE 286 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 283 TABLE 287 INDIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 288 INDIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 284 TABLE 289 INDIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 285 TABLE 290 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 291 AUSTRALIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 292 AUSTRALIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 293 AUSTRALIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 287 TABLE 294 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 295 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 296 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 297 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 298 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 299 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 300 AUSTRALIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 290 TABLE 301 AUSTRALIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 290 TABLE 302 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 303 SOUTH KOREA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 304 SOUTH KOREA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 305 SOUTH KOREA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 306 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 307 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 308 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 309 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 310 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 311 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 312 SOUTH KOREA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 295 TABLE 313 SOUTH KOREA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 296 TABLE 314 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 315 REST OF ASIA PACIFIC: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 316 REST OF ASIA PACIFIC: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 317 REST OF ASIA PACIFIC: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 298 TABLE 318 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 319 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 320 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 321 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 322 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 323 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 324 REST OF ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 301 TABLE 325 REST OF ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 301 TABLE 326 LATIN AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 302 TABLE 327 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 328 LATIN AMERICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 329 LATIN AMERICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 330 LATIN AMERICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 331 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 332 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 333 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 334 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 335 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 336 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 337 LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 306 TABLE 338 LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 307 TABLE 339 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 340 BRAZIL: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 341 BRAZIL: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 342 BRAZIL: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 309 TABLE 343 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 344 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 345 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 346 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 347 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 348 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 349 BRAZIL: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 311 TABLE 350 BRAZIL: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 312 TABLE 351 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 352 MEXICO: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 353 MEXICO: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 354 MEXICO: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 314 TABLE 355 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 356 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 357 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 315 TABLE 358 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 315 TABLE 359 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 316 TABLE 360 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 316 TABLE 361 MEXICO: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 316 TABLE 362 MEXICO: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 317 TABLE 363 COLOMBIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 364 COLOMBIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 365 COLOMBIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 366 COLOMBIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 319 TABLE 367 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 368 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 369 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 370 COLOMBIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 371 COLOMBIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 372 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 373 COLOMBIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 321 TABLE 374 COLOMBIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 322 TABLE 375 REST OF LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 376 REST OF LATIN AMERICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 377 REST OF LATIN AMERICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 378 REST OF LATIN AMERICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 323 TABLE 379 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 380 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 381 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 382 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 383 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 384 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 326 TABLE 385 REST OF LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 326 TABLE 386 REST OF LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 326 TABLE 387 MIDDLE EAST & AFRICA: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET, BY REGION, 2024–2031 (USD MILLION) 327 TABLE 388 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 327 TABLE 389 MIDDLE EAST & AFRICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 390 MIDDLE EAST & AFRICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 391 MIDDLE EAST & AFRICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 328 TABLE 392 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 393 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 394 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 395 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 330 TABLE 396 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 330 TABLE 397 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 331 TABLE 398 MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 331 TABLE 399 MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 332 TABLE 400 GCC COUNTRIES: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 333 TABLE 401 GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 333 TABLE 402 GCC COUNTRIES: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 334 TABLE 403 GCC COUNTRIES: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 334 TABLE 404 GCC COUNTRIES: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 334 TABLE 405 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 335 TABLE 406 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 335 TABLE 407 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 335 TABLE 408 GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 409 GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 410 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 337 TABLE 411 GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 337 TABLE 412 GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 338 TABLE 413 KINGDOM OF SAUDI ARABIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 414 KINGDOM OF SAUDI ARABIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 415 KINGDOM OF SAUDI ARABIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 416 KINGDOM OF SAUDI ARABIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 340 TABLE 417 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 340 TABLE 418 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 340 TABLE 419 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 341 TABLE 420 KINGDOM OF SAUDI ARABIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 341 TABLE 421 KINGDOM OF SAUDI ARABIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 342 TABLE 422 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 342 TABLE 423 KINGDOM OF SAUDI ARABIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 343 TABLE 424 KINGDOM OF SAUDI ARABIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 343 TABLE 425 UAE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 426 UAE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 427 UAE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 428 UAE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 345 TABLE 429 UAE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 430 UAE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 431 UAE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 432 UAE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 433 UAE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 347 TABLE 434 UAE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 347 TABLE 435 UAE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 348 TABLE 436 UAE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 348 TABLE 437 REST OF GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 438 REST OF GCC COUNTRIES: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 439 REST OF GCC COUNTRIES: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 350 TABLE 440 REST OF GCC COUNTRIES: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 350 TABLE 441 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 350 TABLE 442 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 443 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 444 REST OF GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 445 REST OF GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 446 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 447 REST OF GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 353 TABLE 448 REST OF GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 354 TABLE 449 REST OF MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 355 TABLE 450 REST OF MIDDLE EAST & AFRICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 355 TABLE 451 REST OF MIDDLE EAST & AFRICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 355 TABLE 452 REST OF MIDDLE EAST & AFRICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 356 TABLE 453 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 356 TABLE 454 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 356 TABLE 455 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 357 TABLE 456 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 357 TABLE 457 REST OF MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 358 TABLE 458 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 358 TABLE 459 REST OF MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 359 TABLE 460 REST OF MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 359 TABLE 461 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 360 TABLE 462 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: DEGREE OF COMPETITION, 2025 363 TABLE 463 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: REGION FOOTPRINT 370 TABLE 464 CARDIAC MONITORING DEVICES MARKET: TYPE FOOTPRINT 371 TABLE 465 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: TYPE FOOTPRINT 372 TABLE 466 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: APPLICATION FOOTPRINT 373 TABLE 467 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 376 TABLE 468 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TYPE AND REGION 376 TABLE 469 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–NOVEMBER 2025 378 TABLE 470 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: DEALS, JANUARY 2023–NOVEMBER 2025 380 TABLE 471 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: EXPANSIONS, JANUARY 2023–NOVEMBER 2025 382 TABLE 472 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2023–NOVEMBER 2025 383 TABLE 473 GE HEALTHCARE: COMPANY OVERVIEW 385 TABLE 474 GE HEALTHCARE: PRODUCTS OFFERED 387 TABLE 475 GE HEALTHCARE: DEALS, JANUARY 2023–JANUARY 2026 388 TABLE 476 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2023–JANUARY 2026 389 TABLE 477 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 391 TABLE 478 KONINKLIJKE PHILIPS N. V.: PRODUCTS OFFERED 392 TABLE 479 KONINKLIJKE PHILIPS N. V.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 395 TABLE 480 KONINKLIJKE PHILIPS N. V.: DEALS, JANUARY 2023–JANUARY 2026 396 TABLE 481 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023–JANUARY 2026 397 TABLE 482 KONINKLIJKE PHILIPS N. V.: OTHER DEVELOPMENTS, JANUARY 2023–JANUARY 2026 397 TABLE 483 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 399 TABLE 484 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 400 TABLE 485 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2023–JANUARY 2026 402 TABLE 486 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2023–JANUARY 2026 403 TABLE 487 BAXTER (HILL-ROM HOLDINGS, INC.): COMPANY OVERVIEW 404 TABLE 488 BAXTER (HILL-ROM HOLDINGS, INC.): PRODUCTS OFFERED 405 TABLE 489 MEDTRONIC: COMPANY OVERVIEW 408 TABLE 490 MEDTRONIC: PRODUCTS OFFERED 410 TABLE 491 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2023–JANUARY 2026 414 TABLE 492 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 416 TABLE 493 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 417 TABLE 494 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JANUARY 2026 419 TABLE 495 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2023–JANUARY 2026 419 TABLE 496 ABBOTT: COMPANY OVERVIEW 420 TABLE 497 ABBOTT: PRODUCTS OFFERED 421 TABLE 498 ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JANUARY 2026 423 TABLE 499 STRYKER: COMPANY OVERVIEW 424 TABLE 500 STRYKER: PRODUCTS OFFERED 426 TABLE 501 STRYKER: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 426 TABLE 502 STRYKER: DEALS, JANUARY 2023–JANUARY 2026 427 TABLE 503 STRYKER: OTHER DEVELOPMENTS, JANUARY 2023–JANUARY 2026 427 TABLE 504 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 428 TABLE 505 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 429 TABLE 506 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 432 TABLE 507 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 433 TABLE 508 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–JANUARY 2026 435 TABLE 509 FUKUDA DENSHI: COMPANY OVERVIEW 437 TABLE 510 FUKUDA DENSHI: PRODUCTS OFFERED 438 TABLE 511 OSI SYSTEMS, INC.: COMPANY OVERVIEW 441 TABLE 512 OSI SYSTEMS, INC.: PRODUCTS OFFERED 442 TABLE 513 OSI SYSTEMS, INC.: EXPANSIONS, JANUARY 2023–JANUARY 2026 444 TABLE 514 IRHYTHM INC.: COMPANY OVERVIEW 445 TABLE 515 IRHYTHM INC.: PRODUCTS OFFERED 446 TABLE 516 IRHYTHM INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–JANUARY 2026 446 TABLE 517 IRHYTHM INC.: DEALS, JANUARY 2023–JANUARY 2026 447 TABLE 518 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 448 TABLE 519 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED 449 TABLE 520 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 452 TABLE 521 ALIVECOR, INC.: COMPANY OVERVIEW 453 TABLE 522 ALIVECOR, INC.: PRODUCTS OFFERED 453 TABLE 523 ALIVECOR, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–JANUARY 2026 454 TABLE 524 ALIVECOR, INC.: DEALS, JANUARY 2023–JANUARY 2026 454 TABLE 525 SCHILLER: COMPANY OVERVIEW 456 TABLE 526 CARDIAC INSIGHT, INC.: COMPANY OVERVIEW 457 TABLE 527 BIOTRONIK: COMPANY OVERVIEW 458 TABLE 528 BITTIUM: COMPANY OVERVIEW 459 TABLE 529 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW 460 TABLE 530 LIFESIGNALS: COMPANY OVERVIEW 461 TABLE 531 CUMEDICAL: COMPANY OVERVIEW 462 TABLE 532 BIOTRICITY: COMPANY OVERVIEW 463 TABLE 533 EDAN INSTRUMENTS, INC.: COMPANY OVERVIEW 464 TABLE 534 VITALCONNECT: COMPANY OVERVIEW 465 TABLE 535 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: STUDY ASSUMPTIONS 478 TABLE 536 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: RISK ANALYSIS 479 FIGURE 1 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SEGMENTATION & REGIONAL SCOPE 44 FIGURE 2 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: YEARS CONSIDERED 45 FIGURE 3 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SCENARIO 49 FIGURE 4 GLOBAL CARDIAC MONITORING AND RHYTHM MANAGEMENT MARKET DEVICES MARKET SIZE, 2024–2031 (USD MILLION) 49 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2022–2025 50 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 51 FIGURE 7 HIGH-GROWTH SEGMENTS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2026–2031 52 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR, IN TERMS OF VALUE, DURING FORECAST PERIOD 53 FIGURE 9 HIGH CARDIOVASCULAR DISEASE INCIDENCE AND SHIFT TOWARD CONTINUOUS MONITORING TO ACCELERATE MARKET EXPANSION 54 FIGURE 10 CHINA AND ARRHYTHMIA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 55 FIGURE 11 INDIA TO WITNESS HIGHEST CAGR FROM 2026 TO 2031 56 FIGURE 12 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57 FIGURE 13 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS 68 FIGURE 14 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: SUPPLY CHAIN ANALYSIS 71 FIGURE 15 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS 72 FIGURE 16 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: ECOSYSTEM ANALYSIS 73 FIGURE 17 AVERAGE SELLING PRICE OF HOLTER MONITORS, BY KEY PLAYER, 2025 (USD) 75 FIGURE 18 AVERAGE SELLING PRICE OF EXTERNAL DEFIBRILLATORS, BY KEY PLAYER, 2024 (USD) 76 FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 80 FIGURE 20 INVESTMENT AND FUNDING SCENARIO FOR CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET PLAYERS 80 FIGURE 21 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: PATENT ANALYSIS, JANUARY 2014–NOVEMBER 2025 93 FIGURE 22 AI USE CASES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 97 FIGURE 23 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES 110 FIGURE 24 KEY BUYING CRITERIA FOR CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICE PLAYERS 111 FIGURE 25 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT 192 FIGURE 26 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT 263 FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2022–2024 (USD MILLION) 362 FIGURE 28 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SHARE ANALYSIS (2025) 363 FIGURE 29 US CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SHARE ANALYSIS (2025) 365 FIGURE 30 EUROPE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE ANALYSIS (2025) 365 FIGURE 31 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: BRAND COMPARATIVE ANALYSIS 366 FIGURE 32 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 368 FIGURE 33 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: COMPANY FOOTPRINT 369 FIGURE 34 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 375 FIGURE 35 EV/EBITDA OF KEY VENDORS 377 FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 377 FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT 386 FIGURE 38 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 392 FIGURE 39 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 400 FIGURE 40 BAXTER (HILL-ROM HOLDINGS, INC.): COMPANY SNAPSHOT 405 FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT 409 FIGURE 42 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT 417 FIGURE 43 ABBOTT: COMPANY SNAPSHOT 421 FIGURE 44 STRYKER: COMPANY SNAPSHOT 425 FIGURE 45 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 429 FIGURE 46 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 433 FIGURE 47 FUKUDA DENSHI: COMPANY SNAPSHOT 438 FIGURE 48 OSI SYSTEMS, INC.: COMPANY SNAPSHOT 442 FIGURE 49 IRHYTHM INC.: COMPANY SNAPSHOT 445 FIGURE 50 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT 449 FIGURE 51 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: RESEARCH DESIGN 466 FIGURE 52 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES 468 FIGURE 53 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: KEY PRIMARY SOURCES 469 FIGURE 54 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: INSIGHTS FROM KEY PRIMARIES 470 FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 471 FIGURE 56 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 471 FIGURE 57 CARDIAC MONITORING DEVICES MARKET (INVASIVE AND NON-INVASIVE DEVICE TYPE) SIZE ESTIMATION: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) 472 FIGURE 58 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: TOP-DOWN APPROACH 474 FIGURE 59 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: BOTTOM-UP APPROACH 474 FIGURE 60 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: CAGR PROJECTIONS (SUPPLY SIDE) 476 FIGURE 61 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: DATA TRIANGULATION METHODOLOGY 477

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們